logo
Sign in

DNA Stock Price, Chart, Stats & News

Ginkgo Bioworks Holdings, Inc.
Save
635.61M
Market cap
Current P/E
Forward P/E

DNA chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
81.48%
Operating margin
-185.29%
Pretax margin
-184.30%
Net margin
-183.81%
Effective tax rate
0.27%
ROA
-27.93%
ROE
-53.72%
D/E
0.82x
Interest coverage ratio

DNA valuation

P/E
P/S
2.16x
P/B
0.65x
P/CF
-1.92x
P/FCF
-1.89x
P/OCF
-1.92x
PEG
-0.10x
EV multiple
-0.54x

About

Ginkgo Bioworks Holdings, Inc., alongside its subsidiary entities, provides an advanced technological platform focused on the engineering of cells. This proprietary system is utilized to manipulate cellular functions, facilitating the biological creation of various products. These outputs span from innovative pharmaceutical treatments and vital food components to sustainable chemicals designed to replace those traditionally sourced from petroleum.

Similar securities

Based on sector and market capitalization

Report issue